In good agreement, low expression of ZBTB18 mRNA was significantly associated with shorter survival in an independent cohort of 55 Stage III colorectal cancer patients from the TCGA cohort [3, 17] (Additional file 1: Fig. S13). The gene discussed is ZBTB18; the disease is colorectal cancer.